Tuberculosis

Tuberculosis (TB) is a bacterial infection caused by a germ called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes or talks. If you think you have been exposed, you should go to your doctor for tests as soon as possible. You are more likely to get TB if you have a weak immune system.

What is Tuberculosis?

Tuberculosis (TB) is a dreaded bacterial infection. It has been known to mankind since ancient ages. It was commonly called “consumption” at the turn of the last century because of the way the disease seemed to “consume” the individual it affected.

How Has The COVID-19 Pandemic Affected Tuberculosis Eradication?

Tuberculosis Causes

Tuberculosis Diagnosis

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

Latest Tuberculosis News and Research

Researchers focus on how bacterial cells adapt and resist antibiotics

Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities.

26 May 2022

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers reviewed available mucosal vaccines discussing the current challenges and ways to advance the existing approaches.

25 May 2022

UVA scientists make progress in their longstanding efforts to combat tuberculosis

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization reports.

23 May 2022

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modeling study published in The Lancet Global Health.

20 May 2022

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published at the ATS 2022 international conference.

18 May 2022

Researchers use bacteriophages to treat antibiotic-resistant mycobacterial lung infection

For the first time, researchers have successfully used bacteriophages – viruses that kill bacteria – to treat an antibiotic-resistant mycobacterial lung infection, clearing the way for a young National Jewish Health patient with cystic fibrosis to receive a life-saving lung transplant.

13 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

In this study, the authors have specifically studied the interactions of epithelial cells, a subset of cytokines and macrophages.

10 May 2022

New genetic markers could improve early detection of drug-resistant tuberculosis

To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year.

9 May 2022

Researchers investigate IgG antibodies against Mtb proteins in an Asian elephant cured of tuberculosis

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb); the leading cause of human death due to a single pathogen before the emergence of SARS-CoV-2.

9 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill them.

4 May 2022

Researchers reveal the mechanism of action of century-old BCG vaccine

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.

4 May 2022

New insight into the body’s response to tuberculosis may help design a more effective vaccine

More than 1.7 billion people-; or a quarter of the world's population-; are infected with Mycobacterium tuberculosis, the bacterial strain that causes tuberculosis (TB).

27 Apr 2022

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

As part of World Immunization Week 2022, News Medical speaks to the International Vaccine Institute about their fight against vaccine inequity, as well as what a “Long Life for All” means to them.

25 Apr 2022

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, the researchers investigated the impact of Bacillus Calmette-Guérin (BCG) vaccine-induced antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein.

25 Apr 2022

Tuberculosis

Overview

How Has The COVID-19 Pandemic Affected Tuberculosis Eradication?

Tuberculosis Causes

Tuberculosis Diagnosis

Feature Articles

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

Latest Tuberculosis News and Research

Researchers focus on how bacterial cells adapt and resist antibiotics

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

UVA scientists make progress in their longstanding efforts to combat tuberculosis

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Researchers use bacteriophages to treat antibiotic-resistant mycobacterial lung infection

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

New genetic markers could improve early detection of drug-resistant tuberculosis

Researchers investigate IgG antibodies against Mtb proteins in an Asian elephant cured of tuberculosis

Evaluation of the potential of new and repurposed TB vaccines

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Researchers reveal the mechanism of action of century-old BCG vaccine

New insight into the body’s response to tuberculosis may help design a more effective vaccine

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

Moisture in the air crucial for the survival and spread of tuberculosis

Revolutionary mRNA vaccine technology: History, facts and the future

Two strains of TB bacterium attack the lungs in completely different fashion, study finds

Monitoring medication adherence for TB treatment in Africa using AI

Using AI to Achieve Earlier Diagnosis of Pancreatic Cancer

Improving Patient Recruitment for Clinical Trial Research

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

Tuberculosis

Overview

Feature Articles

Tuberculosis Prevention

Tuberculosis Screening

Tuberculosis Treatment

Tuberculosis Prognosis

History of Tuberculosis

Tuberculosis in Animals

Tuberculosis Transmission

New tuberculosis technologies: importance of access in the private health sector

Latest Tuberculosis News and Research

Using AI to Achieve Earlier Diagnosis of Pancreatic Cancer

Improving Patient Recruitment for Clinical Trial Research

Micro Products with Macro Impact; The Role of Microplate Readers in Life Sciences

Newsletters you may be interested in